Robert Michael Dudley, CEO: Transcode Therapeutics RNAZ Buy · Filed 23/06/22

Trade details

Type: Insider buy
Amount: $31,800
Shares · price: 12,000 sh · $2.65 a share
Held after: 82,262 sh
Stock: Transcode Therapeutics RNAZ
Person: Robert Michael DudleyCEO
Trade date: 23/06/21
Filed: 23/06/22
Days to filing: 1 days

Holdings up 17.1%

Insiders buying this week: 1 insiders
Holding change: +17.1%

Transcode Therapeutics trades, last 26 weeks

What else happened in Transcode Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/22~23/07/21

Robert Michael Dudley's recent trades

Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$50K
98,000 sh
$50K
Filed 23/10/02
Traded 23/09/28
Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$16.8K
6,607 sh
$16.8K
Filed 23/06/22
Traded 23/06/20
Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$52.4K
19,000 sh
$52.4K
Filed 23/06/14
Traded 23/06/09
Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$52.4K
19,000 sh
$52.4K
Filed 23/06/13
Traded 23/06/09